IDEX Biometrics ASA IDXAF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 54.23% | 1.18% | 24.84% | -172.94% | 70.32% |
| Total Depreciation and Amortization | -74.46% | -72.90% | -95.11% | 135.20% | -87.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -19.70% | 202.61% | 87.76% | 79.41% | -282.55% |
| Change in Net Operating Assets | -286.38% | 87.92% | -45.92% | -128.03% | 33,900.00% |
| Cash from Operations | -211.68% | 63.57% | 46.11% | -12.59% | 71.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 250.00% | -841.67% | -102.47% | 220.00% | -105.00% |
| Cash from Investing | 250.00% | -841.67% | -1,633.33% | 164.00% | -100.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9.81% | -- | 69.23% | 83.76% | -1,804.37% |
| Issuance of Common Stock | 176.88% | -- | -65.03% | 44.06% | 599.69% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 104.28% | -- | -- | -- |
| Cash from Financing | 433.12% | -73.26% | -64.95% | 100.84% | -63.96% |
| Foreign Exchange rate Adjustments | -79.62% | -239.47% | 88.89% | -345.45% | 783.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | 200.00% | -- | -- |
| Net Change in Cash | 4,402.80% | 43.21% | -137.35% | 106.86% | 93.47% |